2023 Cancer Immunotherapy Summit: Everything, Everywhere, All At Once

Coeur d'Alene, ID US
September 22, 2023 to September 23, 2023

This CME-accredited conference, "2023 Cancer Immunotherapy Summit: Everything, Everywhere, All At Once," features leading experts in the field who will provide a comprehensive overview of current and emerging strategies to integrate immunotherapy in the management of cancers. These experts will offer their insights on mechanisms of immunotherapy toxicity, host factors regulating efficacy and resistance, and neoadjuvant immunotherapy, all in the pursuit of improving patient outcomes. This activity aims to enhance learners' knowledge and competence to apply practice-changing clinical data and expert recommendations to incorporate immunotherapy and optimize clinical outcomes for cancer patients. The oncology conference will use a mix of didactic lectures and case-based panel discussions to highlight areas of debate in the field of immuno-oncology. Expert faculty will aim to place the role of different therapeutic agents in a clinical context and discuss how to utilize these therapeutic options to contribute effectively to patient care.

Target Audience

  • Medical oncologists

  • Hematologist oncologists

  • Oncology/Hematology residents/fellows

  • Oncology NPs/PAs

  • Oncology pharmacists

  • Oncology nurses

Learning Objectives

  • Review mechanisms of action of currently approved and emerging immunotherapies
  • Review indications and outcomes of approved immunotherapies.
  • Identify and manage complications of immunotherapies.
  • State the financial, physical, and other barriers, and review strategies to navigate these factors to optimize the management of patients with immunotherapies.
  • Discuss novel neoadjuvant and adoptive therapies in the management of cancers.
  • Incorporate biomarkers in the management plan of cancers. 
Course summary
Available credit: 
  • 10.75 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 10.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 10.75 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 10.75 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 10.75 Contact Hours.
Course opens: 
05/25/2023
Course expires: 
09/23/2023
Event starts: 
09/22/2023 - 3:00pm PDT
Event ends: 
09/23/2023 - 5:30pm PDT
Cost:
$150.00

Conference Chair: Dr. Shailender Bhatia

 

DAY 1 - September 22, 2023


All times below are listed in Pacific Standard Time (PST).


03:00PM – 06:00 PM: SESSION I: IMMUNOTHERAPY MODALITIES: MECHANISMS OF ACTION
Moderator: TBD

03:00 PM - 03:15 PM: Welcome, introductions and pre-tests - 

03:15 PM - 03:40 PM: Immuno-checkpoint inhibitors: old and new - 

03:40 PM - 04:05 PM: Adoptive T cell therapy: what is on the horizon? - 

04:05 PM - 04:30 PM: T-cell antagonists and bispecific T-cell engagers

04:30 PM - 04:55 PM: Harnessing innate immunity (NK cells, TLRs, MDSCs etc..)

04:55 PM - 05:00 PM: Post-test

05:00 PM - 06:00 PM: Panel discussion: financial toxicity


DAY 2 - September 23, 2023

08:00 AM - 10:00 AM: SESSION I: IMMUNOTHERAPY MODALITIES: MECHANISMS OF ACTION
Moderator: TBD

08:00 AM - 08:10 AM: Welcome and pre-test 

08:10 AM - 08:35 AM: Skin cancers (melanoma and non-melanoma skin cancers)

08:35 AM - 09:00 AM: Lung cancer

09:00 AM - 09:25 AM: Women's cancers (breast, gynecologic malignancies)

09:25 AM - 09:30 AM: Post-test

09:30 AM - 10:00 AM: Panel discussion: duration of therapy


10:00 AM - 10:30 AM: BREAK AND NETWORKING


10:30 AM - 12:00 PM: SESSION III: IMMUNOTHERAPY BIOMARKERS
Moderator: 

10:30 AM - 10:35 AM: Pre-test

10:35 AM - 11:00 AM: PD-L1

11:00 AM - 11:25 AM: TILs

11:25 AM - 11:50 AM: TMB

11:50 AM - 12:00 PM: Post-test


12:00 PM - 01:00 PM: LUNCH AND NETWORKING


01:00 PM - 01:45 PM: Keynote lecture - Cancer vaccines: the future is bright

01:45 PM - 03:15 PM: SESSION IV: UPDATES IN CANCER IMMUNOTHERAPY (PART 2)

01:45 PM - 01:50 PM: Pre-test

01:50 PM - 02:10 PM: Urotherial cancer

02:10 PM - 02:30 PM: Multiple Myeloma

02:30 PM - 02:50 PM: Renal cell carcinoma

02:50 PM - 02:55 PM: Post-test

02:55 PM - 03:15 PM: Panel discussion: Access to cellular therapy in academia and community


03:15 PM - 03.30: BREAK


03:30 PM - 05:30 PM: IMMUNE-RELATED ADVERSE EVENTS

03:30 PM - 03:35 PM: Pre-test

03:35 PM - 03:55 PM: Colitis

03:55 PM - 04:15 PM: Rheumatologic toxicities

04:15 PM - 04:35 PM: Myocarditis

04:35 PM - 04:55 PM: Dermatologic toxicities

04:55 PM - 05:00 PM: Post-test

05:00 PM - 05:30 PM: Panel discussion: Use of ICIs in pre-existing autoimmunity/organ transplant/prior IRAEs

Coeur d'Alene Resort
115 S 2nd St
Coeur d'Alene, ID 83814
United States

The Coeur d'Alene Resort

 

FACULTY INFORMATION COMING SOON

 

Course Director(s)

Binay Shah, MD, MHA

has no relevant financial relationships to disclose at this time.
Planner(s)

Binay Shah, MD, MHA

has no relevant financial relationships to disclose at this time.

Available Credit

  • 10.75 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 10.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 10.75 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 10.75 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 10.75 Contact Hours.

If you are interested in exhibiting at this meeting, please visit our exhibit page here - https://education.binayfoundation.org/exhibit-information

 

Price

Cost:
$150.00
Please login or register to take this course.

NOTICE TO HCPS EMPLOYED BY THE INDUSTRY:

If you are employed by industry, including pharmaceuticals and biotech companies, you must pay the INDUSTRY REGISTRATION FEE to participate in any meeting organized by the Binaytara Foundation. If you misrepresented yourself as a healthcare provider not employed by the industry and failed to pay the Industry registration fee, the following fees apply:

  • If your company has purchased a display table at the event, you will be billed the full INDUSTRY REGISTRATION FEE plus a fine equivalent to the full industry registration fee for that event = 2 X the industry registration fee.
  • If your company has NOT purchased a display table at the event AND you attended the meeting without paying a full industry registration fee, you will be billed a full GENERAL DISPLAY FEE for that event. 

Any outstanding display fee, registration fee, and fines must be paid before the industry employee or the company will be able to attend/display at our conferences again.

CANCELLATION POLICY

You may cancel your enrollment at any time. Cancellation fees apply as below:

  • 50% of the paid registration fee will be refunded if registration is cancelled six weeks before the conference.
  • No refunds will be issued if registration is cancelled after that date.  

No credits will be offered if you do not complete all required steps of this activity which include registration, participation in the live activity, and completion of pre & post tests as well as course evaluations.